Literature DB >> 1289420

Expression of the human MUC1 mucin cDNA in a hamster pancreatic tumor cell line HP-1.

S K Batra1, R S Metzgar, A J Worlock, M A Hollingsworth.   

Abstract

A full length cDNA for the human mucin gene, MUC1, under the control of human beta actin promoter, was transfected into a carcinogen induced hamster pancreatic ductal tumor cell line, HP-1. Transfectants were selected by resistance to geneticin. Integration of the foreign human MUC1 cDNA occurred at multiple sites in the genome of HP-1. Northern blot analysis showed MUC1 expression in cells transfected with MUC1 cDNA placed in the correct orientation, but not in control cells (HP-1 cells transfected with vector alone, or with the MUC1 cDNA placed in the antisense orientation). Western blot analysis using monoclonal antibody HMFG-2, which is reactive with the MUC1 protein, showed results consistent with the Northern blot data. Positive immunoperoxidase staining using HMFG-2 was seen in HP-1 cells transfected with MUC1 cDNA but not with untransfected or HP-1 control cells. The integration of human MUC1 mucin gene in HP-1 cells caused no significant change in the growth rate of HP-1 cells in vitro, but resulted in an enhanced growth rate for xenografts of MUC1 transfected HP-1 cells grown in nude mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1289420     DOI: 10.1007/bf02924367

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  19 in total

1.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Report on the first international workshop on carcinoma-associated mucins.

Authors:  J Taylor-Papadimitriou
Journal:  Int J Cancer       Date:  1991-08-19       Impact factor: 7.396

3.  Cloning and sequencing of a human pancreatic tumor mucin cDNA.

Authors:  M S Lan; S K Batra; W N Qi; R S Metzgar; M A Hollingsworth
Journal:  J Biol Chem       Date:  1990-09-05       Impact factor: 5.157

4.  Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini.

Authors:  M J Ligtenberg; H L Vos; A M Gennissen; J Hilkens
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

5.  Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.

Authors:  D L Barnd; M S Lan; R S Metzgar; O J Finn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  Characterization of clones of a human pancreatic adenocarcinoma cell line representing different stages of differentiation.

Authors:  Y W Kim; H F Kern; T D Mullins; M J Koriwchak; R S Metzgar
Journal:  Pancreas       Date:  1989       Impact factor: 3.327

7.  Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas.

Authors:  G R Merlo; J Siddiqui; C S Cropp; D S Liscia; R Lidereau; R Callahan; D W Kufe
Journal:  Cancer Res       Date:  1989-12-15       Impact factor: 12.701

8.  Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin.

Authors:  S J Gendler; C A Lancaster; J Taylor-Papadimitriou; T Duhig; N Peat; J Burchell; L Pemberton; E N Lalani; D Wilson
Journal:  J Biol Chem       Date:  1990-09-05       Impact factor: 5.157

9.  Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.

Authors:  K R Jerome; D L Barnd; K M Bendt; C M Boyer; J Taylor-Papadimitriou; I F McKenzie; R C Bast; O J Finn
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

10.  Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease.

Authors:  P M Pour; R G Runge; D Birt; R Gingell; T Lawson; D Nagel; L Wallcave; S Z Salmasi
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.